# Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

> **NCT07242638** · PHASE2 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 56 (estimated)

## Conditions studied

- Atopic Dermatitis
- Alopecia Areata

## Interventions

- **DRUG:** Abrocitinib

## Key facts

- **NCT ID:** NCT07242638
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-12
- **Primary completion:** 2027-03-01
- **Final completion:** 2028-03-03
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07242638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07242638, "Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT07242638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*